Sleep apnea is highly prevalent in patients with cardiovascular disease. These disordered
breathing events are associated with a profile of perturbations that include intermittent …

The obstructive sleep apnea syndrome (OSAS) represents only part of a large group of
pathologies of variable entity called respiratory sleep disorders (RSD) which include simple …

Aim To determine the accuracy of biomarker combinations in gingival crevicular fluid (GCF)
and saliva through meta‐analysis to diagnose periodontitis in systemically healthy subjects …

Aim To analyse, using a meta‐analytical approach, the diagnostic accuracy of single
molecular biomarkers in saliva for the detection of periodontitis in systemically healthy …

Obstructive sleep apnea (OSA) is a prevalent, underdiagnosed disease that imposes a
significant impact on the health and wellbeing of patients and a financial burden on …

Obstructive sleep apnea syndrome (OSAS) may be central neurologic (< 5%) or obstructive
(> 95%) in origin and is a relatively prevalent condition in children. It affects 1%-5% of …

Summary Background Obstructive Sleep Apnea (OSA) has been recognized as a major
health concern worldwide, given its increasing prevalence, difficulties in diagnosis and …

Obstructive sleep apnea (OSA) is a prevalent and underdiagnosed condition associated
with cardiovascular diseases, depression, accidents, and stroke. There is an increasing …

The impact of advances in sleep and circadian sciences over the last 20 years on medicine,
health, and public safety has been limited in part by the lack of availability of objective tools …

Systemic inflammation is important in obstructive sleep apnea (OSA) pathophysiology and
its comorbidity. We aimed to assess the levels of inflammatory biomarkers in a large sample …